Skip to main navigation Skip to search Skip to main content

Description

Researchers at CityU have identified and demonstrated for the first time a therapeutic small molecule, M1, that can restore the visual function in the mammalian central nervous system, offering hope for patients with optic nerve damage such as glaucoma-related vision loss.
Period16 Jan 2023

Media coverage

5

Media coverage

Keywords

  • CityU NewsCentre
  • Last Changed: 2023-02-27 09:05:15